FDA

About the union

FDA is a certificated independent trade union. Its directory sectors include Civil Service, Public Services, Senior Management. Listed occupational groups include Civil servants, Senior public service managers.

Certificate of Independence: Certificated independent

Sectors: Civil Service, Public Services, Senior Management

Occupations they support
  • Civil servants
  • Senior public service managers

Union Overview

The FDA represents professionals, managers and senior specialists in the UK civil service and wider public service. Its published eligibility criteria include civil servants at Higher Executive Officer grade and above, Fast Stream entrants, and Foreign, Commonwealth and Development Office staff at any grade. The union also represents professionals in prosecution, legal, diplomatic and policy occupations and is involved in the Managers in Partnership arrangement with UNISON for health managers.

Its distinctive bargaining constituency includes staff with substantial responsibility for implementing public policy and managing public functions. This is not an employer association: its purpose is collective and individual representation of eligible workers, notwithstanding the seniority of some members.

Membership and Representation

The FDA states that it represents members across more than 200 government departments, agencies and arm’s-length bodies in the UK and overseas. It includes representation within devolved administrations. The profile should distinguish the breadth of represented organisations from the number of members: they are different measures.

A current audited total membership figure has not been extracted and verified for this draft. The latest Certification Officer annual return should supply the figure and its accounting year before a numerical total is added to the website.

Organisational Structure

The FDA describes a federal structure of workplace- and professional-interest-based branches and sections, with elected representatives, an Executive Committee and an Annual Delegate Conference determining overall policy. The General Secretary and President are elected; officials support member representation and negotiations.

Dave Penman is identified by the FDA as General Secretary and the union records his re-election in 2026. The website also names Lauren Crowley as Assistant General Secretary. Named appointments should be checked again at the point of publication.

Recognition and Collective Bargaining

The FDA undertakes collective representation on pay, progression, pensions and employment policy, in addition to individual workplace advocacy. Negotiations can be shaped by centrally determined civil service pay remits, departmental bargaining arrangements, Senior Salaries Review Body recommendations and devolved public-service frameworks. These mechanisms are not interchangeable: an employer should identify the specific employee group and bargaining machinery before determining its obligations.

FDA membership among senior managers does not, by itself, establish that every individual employer recognises it for the same bargaining unit or scope of negotiation. The existence and scope of a particular recognition agreement must be checked with the employer and the relevant union representatives.

Industrial Relations Priorities

The FDA’s 22 May 2026 response to the Civil Service Pay Remit Guidance welcomed steps towards Senior Civil Service pay progression while identifying pay progression for the wider delegated grades as a continuing leading priority. It also discussed pay compression, recruitment and retention and the limitations of the existing reward framework.

In public communications the union advocates a properly independent pay-review mechanism and strengthened bargaining rights. These are the FDA’s policy positions, not descriptions of changes already made to law or to every employer’s pay arrangements.

Significant Developments, Litigation and Governance

2026 pay settlement and progression: The FDA reported in May 2026 that the delegated-grade pay remit allowed average awards of up to 3.5%, and that the Senior Civil Service arrangements included a 2.5% base-pay uplift, a 1% progression pot and higher pay-band minima. These are descriptions of announced arrangements and FDA commentary; individual departmental settlements require separate verification.

Sampson v FDA (25 July 2012): A member complained to the Certification Officer about removal from office in a London Branch of the Crown Prosecution Section. The complaint was dismissed following withdrawal by the claimant. No substantive breach finding was made. This historic case must not be represented as proof of wrongdoing by the FDA.

The Certification Officer also lists a historic 1998 statutory balloting procedure decision associated with the FDA’s predecessor name. Its outcome and contemporary relevance should be checked against the underlying decision before any further characterisation.

The information in this profile has been consolidated from the trade union's official website, Certification Officer records and other relevant official sources.

Back to the Trade Union Directory